Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Zealand Pharma
Market Cap: DKK 30.9b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 439.10
7D
-1.7%
1Y
-46.0%
BioPorto
Market Cap: DKK 611.1m
An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally.
BIOPOR
DKK 1.34
7D
3.1%
1Y
-28.0%